Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008500
Filing Date
2025-03-18
Accepted
2025-03-18 18:41:24
Documents
1
Period of Report
2025-03-15

Document Format Files

Seq Description Document Type Size
1 form4-03182025_100320.html 4  
1 form4-03182025_100320.xml 4 5823
  Complete submission text file 0001415889-25-008500.txt   7238
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMPHASTAR PHARMACEUTICALS INC 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address
Liawatidewi Yakob (Reporting) CIK: 0001743927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 25750187